Changing the label

caution warning danger sign thunderstorm
Pharmacists question proposed label and advisory changes for OTC mometasone preparations Both the Pharmacy Guild of Australia and the PSA had concerns over the proposed new advisory statements for labels of over the counter (OTC) medicines containing mometasone in dermal and nasal spray preparations. The proposals are part of a number of advisory label changes

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Vax scheme crucial in light of mandates
Next ‘Skilled con-artist’ exploited pharmacists’ empathy and trust